Biophytis Deploys Its Partnership Strategy and Signs Two Contracts With Local Agents in Asia

AccesswireJul 22 02:30 ET

Biophytis Obtains IND Approval From the FDA to Start Its Phase 2 OBA Study in Obesity

AccesswireJul 11 02:40 ET

Biophytis Presented Its Phase 2-3 COVA Study Results in Severe Forms of Covid-19 at the WCID in Paris

AccesswireJul 1 01:20 ET

6-K: Report of foreign private issuer (related to financial reporting)

SECJun 26 13:48 ET · Announcements

Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million

AccesswireJun 20 01:20 ET

Biophytis Extends Its Contract With Atlas to Secure Financing for Its Business Activities

AccesswireJun 19 19:50 ET